News & Publications | Diatherisdraft

DiaTheris wins first place in >>venture>> startup competition

Out of 336 initial submissions across both Business and NPO Tracks, DiaTheris is the winner of Switzerland's leading early-stage startups...

89 visualizzazioni0 commenti

DiaTheris wins CHF 10,000 at Venture Kick startup competition

DiaTheris adjunct treatment to insulin therapy is one of the six startups to win the first stage prize issued in Venture Kick funding...

35 visualizzazioni0 commenti

An Innosuisse grant for a game-changing diabetes treatment - UNIVERSITY OF GENEVA

https://www.unige.ch/medecine/phym/en/home/an-innosuisse-grant-for-a-game-changing-diabetes-treatment/ Type 1 diabetes is a disease in...

137 visualizzazioni0 commenti

SWISS ACCELERATORS' SHOWCASE

Diatheris will be presented at the Swiss Accelerators' Showcase taking place the 28 November 2022. Meet the founders in the virtual 3D...

36 visualizzazioni0 commenti

'Innovation Day' 2022 at University Hospital of Geneva (16th edition): Award to Diatheris

DIATHERIS has been awarded the Innovation Trophy 2022. The "Diatheris" project, which is developing an approach aimed at overcoming the...

57 visualizzazioni0 commenti

Addio insulina, presto una proteina controllerà i picchi glicemici

L'università di Ginevra lavora su una terapia alternativa basata sulla proteina S100A9, che può regolare la glicemia, i chetoni e i...

70 visualizzazioni0 commenti

Hepatic non-parenchymal S100A9-TLR4-mTORC1axis normalizes diabetic ketogenesis

Unrestrained ketogenesis leads to life-threatening ketoacidosis whose incidence is high in patients with diabetes. While insulin therapy...

108 visualizzazioni0 commenti

Diabetes: a step closer to a life without insulin

A UNIGE team reveals how the S100A9 protein improves metabolism of insulin-dependent diabetics by avoiding the deleterious effects of...

181 visualizzazioni0 commenti